Serum biomarkers for detecting ectopic pregnancy

Clinical Obstetrics and Gynecology

Volumn 55, Issue 2, 2012, Pages 418-423

  Rausch, Mary E ^a   Barnhart, Kurt T ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

biomarkers; Ectopic pregnancy; multiple markers; proteomics; serum test

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; CA 125 ANTIGEN; CHORIONIC GONADOTROPIN; CREATINE KINASE; ESTRADIOL; INHIBIN A; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MYOGLOBIN; MYOSIN HEAVY CHAIN; PLACENTA LACTOGEN; PLACENTA PROTEIN 14; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROGESTERONE; RELAXIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; ECHOGRAPHY; ECTOPIC PREGNANCY; GESTATIONAL SAC; HUMAN; PREGNANCY; PROGESTERONE BLOOD LEVEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS;

ACTIVINS; ADAM PROTEINS; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CHORIONIC GONADOTROPIN; CREATINE KINASE; ESTRADIOL; FEMALE; GLYCOPROTEINS; HUMANS; INHIBINS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA INHIBITORY FACTOR; MEMBRANE PROTEINS; MYOGLOBIN; MYOSIN HEAVY CHAINS; PLACENTAL LACTOGEN; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY, ECTOPIC; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; PROGESTERONE; PROTEOME; RELAXIN; RENIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860304721     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31825109f6     Document Type: Article

References (21)

1. Barnhart KT. Clinical practice. Ectopic pregnancy. N Engl J Med. 2009;361: 379-387.
2. Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res. 2001;480-481:349-358. (Pubitemid 32744841)
3. Cartwright J, Duncan WC, Critchley HO, et al. Serum biomarkers of tubal ectopic pregnancy: Current candidates and future possibilities. Reproduction. 2009;138:9-22.
4. Arck P, Hansen PJ, Mulac Jericevic B, et al. Progesterone during pregnancy: Endocrine-immune cross talk inmammalian species and the role of stress.AmJ Reprod Immunol. 2007;58:268-279. (Pubitemid 47249065)
5. Mol BW, Lijmer JG, Ankum WM, et al. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: A meta-analysis. Hum Reprod. 1998;13:3220-3227. (Pubitemid 28521878)
6. Hall JA, Brown R, Paul J. An exploration into study design for biomarker identification: Issues and recommendations. Cancer Genomics Proteomics. 2007;4:111-119.
7. Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93:1054-1061. (Pubitemid 32717537)
8. Horne AW, Duncan WC, Critchley HO. The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy. Acta Obstet Gynecol Scand. 2010;89:299-301.
9. Rausch ME, Sammel MD, Takacs P, et al. Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol. 2011;117:573-582.
10. Cabar FR, Fettback PB, Pereira PP, et al. Serum markers in the diagnosis of tubal pregnancy. Clinics (Sao Paulo). 2008;63: 701-708.
11. Segal S, Mercado R, Rivnay B. Ectopic pregnancy early diagnosis markers. Minerva Ginecol. 2010;62:49-62.
12. Birkhahn RH, Gaeta TJ, Paraschiv D, et al. Serum levels of myoglobin, creatine phosphokinase, and smooth muscle heavy-chain myosin in patients with ectopic pregnancy. Ann Emerg Med. 2001; 38:628-632. (Pubitemid 33131560)
13. Cabar FR, Pereira PP, Schultz R, et al. Vascular endothelial growth factor and beta-human chorionic gonadotropin are associated with trophoblastic invasion into the tubal wall in ectopic pregnancy. Fertil Steril. 2010;94:1595-1600.
14. Lam PM, Briton-Jones C, Cheung CK, et al. IncreasedmessengerRNAexpression of vascular endothelial growth factor and its receptors in the implantation site of the human oviduct with ectopic gestation. Fertil Steril. 2004;82:686-690. (Pubitemid 39243193)
15. Soriano D, Hugol D, Quang NT, et al. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Fertil Steril. 2003;79:975-980. (Pubitemid 36385023)
16. Mueller MD, Raio L, Spoerri S, et al. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy. Fertil Steril. 2004;81: 1106-1111. (Pubitemid 38452981)
17. Horne AW, DuncanWC, King AE, et al. Endometrial cysteine-rich secretory protein 3 is inhibited by human chorionic gonadotrophin, and is increased in the decidua of tubal ectopic pregnancy. Mol Hum Reprod. 2009;15:287-294.
18. Horne AW, van den Driesche S, King AE, et al. Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab. 2008;93:2375-2382. (Pubitemid 351831561)
19. Beer LA, Tang HY, Sriswasdi S, et al. Systematic discovery of ectopic pregnancy serumbiomarkers using 3-Dprotein profiling coupled with label-free quantitation. J Proteome Res. 2011;10:1126-1138.
20. Gerton GL, Fan XJ, Chittams J, et al. A serum proteomics approach to the diagnosis of ectopic pregnancy. AnnNY Acad Sci. 2004;1022:306-316. (Pubitemid 38951618)
21. Rausch ME, Beer L, SammelMD,et al.A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril. 2011;95: 1373-1378.